That timeline is in line with mine, unless there's a stoppage at an interim analysis. Hospitalisation rates are still trending up with the start of flu season, so maybe Mesoblast does have some reasonable reason to believe recruitment will be faster in the coming months. If not, then the readout could slip back a bit further.
Someone needs to ask them for some justification of their enrollment timelines at the AGM...
@IndexInvestor - I think we're mostly on the same page here.
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-413
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.033(2.98%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.195M | 2.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 34451 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 28192 | 16 |
View Market Depth
| Last trade - 15.22pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |